PCM
RGEN icon

Piermont Capital Management’s Repligen RGEN Stock Holding History

Piermont Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-25,490
Closed -$505K – 254
2014
Q4 		$505K Sell
25,490
-250
-1% -$5.59K 0.18% 105
2014
Q3 		$512K Buy
25,740
+11,480
+81% +$242K 0.2% 105
2014
Q2 		$325K Hold
14,260
– – 0.13% 104
2014
Q1 		$183K Hold
14,260
– – 0.09% 135
2013
Q4 		$195K Buy
+14,260
New +$170K 0.1% 123

Other funds holding RGEN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Piermont Capital Management's RGEN Position: Q1 2015 in Review

Piermont Capital Management sold out of Repligen (RGEN) in Q1 2015, closing a stake of 25,490 shares — an estimated $505K sold.

Piermont Capital Management first reported a position in RGEN in Q4 2013 and held it in 5 quarters. The position peaked at $512K in Q3 2014. 168 funds tracked by Wall St. Rank hold RGEN as of Q1 2015.

  • Piermont Capital Management reported no remaining Repligen position as of Q1 2015 after selling out during the quarter.
  • Piermont Capital Management sold 25,490 Repligen shares in Q1 2015, an estimated $505K.
  • Piermont Capital Management first reported a position in Repligen in Q4 2013 and held it in 5 quarters.
  • Piermont Capital Management's Repligen position peaked at $512K in Q3 2014.
  • 168 funds tracked by Wall St. Rank held Repligen as of Q1 2015.

Based on Piermont Capital Management's 13F filing for Q1 2015, filed 13 May 2015.